{"transactions":[{"id":746378,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T22:01:28.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":20.22,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-262205","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312526262205/ownership.xml","form_type":"4"}},{"id":746377,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T22:01:28.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001193125-26-262205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312526262205/ownership.xml","form_type":"4"}},{"id":848769,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-11T20:13:30.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":37485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 9, 2026 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":37485,"derivative":{"exercise_price":7.03,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":37485},"source":{"system":"sec-edgar","filing":"0001610717-26-000093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071726000093/form4.xml","form_type":"4"}},{"id":1084741,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-18T20:41:45.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":40185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from July 16, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":40185,"derivative":{"exercise_price":8.68,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":40185},"source":{"system":"sec-edgar","filing":"0001610717-25-000286","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071725000286/form4.xml","form_type":"4"}},{"id":1118087,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T21:50:27.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":37500,"derivative":{"exercise_price":3.51,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000950170-25-083911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025083911/ownership.xml","form_type":"4"}},{"id":1118086,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T21:50:27.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000950170-25-083911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025083911/ownership.xml","form_type":"4"}},{"id":1228995,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T21:32:51.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":47271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 28, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":47271,"derivative":{"exercise_price":16.87,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":47271},"source":{"system":"sec-edgar","filing":"0001610717-25-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071725000044/form4.xml","form_type":"4"}},{"id":1412781,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T20:23:49.000Z","date":"2024-09-04","kind":"grant","planned":false,"acquired":true,"shares":10880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from September 4, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":10880,"derivative":{"exercise_price":11.74,"expiration_date":"2034-09-04","underlying":"Common Stock","underlying_shares":10880},"source":{"system":"sec-edgar","filing":"0001610717-24-000466","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000466/form4.xml","form_type":"4"}},{"id":1487037,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T21:16:19.000Z","date":"2024-06-05","kind":"grant","planned":true,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":37500,"derivative":{"exercise_price":7.41,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000950170-24-070875","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024070875/ownership.xml","form_type":"4"}},{"id":1487036,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T21:16:19.000Z","date":"2024-06-05","kind":"sale","planned":true,"acquired":true,"shares":5000,"price":7.2078,"value":36039.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $7.01 to $7.38 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0000950170-24-070875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024070875/ownership.xml","form_type":"4"}},{"id":1487035,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T21:16:19.000Z","date":"2024-06-05","kind":"grant","planned":true,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":11250,"source":{"system":"sec-edgar","filing":"0000950170-24-070875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024070875/ownership.xml","form_type":"4"}},{"id":1603386,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T22:42:56.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":308940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 1, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":308940,"derivative":{"exercise_price":1.13,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":308940},"source":{"system":"sec-edgar","filing":"0001610717-24-000123","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000123/form4.xml","form_type":"4"}},{"id":1612479,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:32:48.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 26,250 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 18,750 shares, having an exercise price of $0.96 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":18750,"derivative":{"exercise_price":0.96,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001610717-24-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000099/form4.xml","form_type":"4"}},{"id":1612478,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:32:48.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":74998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 105,000 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 74,998 shares, having an exercise price of $0.96 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option will vest and become exercisable as to 75% of the total number of shares subject to the option on the one year anniversary of the date of the grant and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued service with the issuer on each such vesting date."}],"balance_after":74998,"derivative":{"exercise_price":0.96,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":74998},"source":{"system":"sec-edgar","filing":"0001610717-24-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000099/form4.xml","form_type":"4"}},{"id":1612477,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:32:48.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":51833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 176,237 of the issuer's shares granted to the reporting person on December 1, 2020. In exchange, on February 28, 2024, the reporting person received a replacement option, for 51,833 shares, having an exercise price of $0.96 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":51833,"derivative":{"exercise_price":0.96,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":51833},"source":{"system":"sec-edgar","filing":"0001610717-24-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000099/form4.xml","form_type":"4"}},{"id":1612476,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:32:48.000Z","date":"2024-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 26,250 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 18,750 shares, having an exercise price of $0.96 per share."}],"balance_after":0,"derivative":{"exercise_price":3.06,"exercise_date":"2025-02-04","expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001610717-24-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000099/form4.xml","form_type":"4"}},{"id":1612475,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:32:48.000Z","date":"2024-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 105,000 of the issuer's shares granted to the reporting person on February 4, 2022. In exchange, on February 28, 2024, the reporting person received a replacement option, for 74,998 shares, having an exercise price of $0.96 per share."}],"balance_after":0,"derivative":{"exercise_price":3.06,"exercise_date":"2022-03-04","expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001610717-24-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000099/form4.xml","form_type":"4"}},{"id":1612474,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:32:48.000Z","date":"2024-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":176237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 176,237 of the issuer's shares granted to the reporting person on December 1, 2020. In exchange, on February 28, 2024, the reporting person received a replacement option, for 51,833 shares, having an exercise price of $0.96 per share."}],"balance_after":0,"derivative":{"exercise_price":16.18,"exercise_date":"2021-01-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":176237},"source":{"system":"sec-edgar","filing":"0001610717-24-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000099/form4.xml","form_type":"4"}},{"id":1783009,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-12T20:07:46.000Z","date":"2023-09-08","kind":"grant","planned":false,"acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from July 20, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":48000,"derivative":{"exercise_price":0.84,"expiration_date":"2033-09-08","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001610717-23-000276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071723000276/form4.xml","form_type":"4"}},{"id":1862576,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T01:39:53.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 6, 2023, subject to the Reporting Person's continuous service  with the Issuer as of each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.55,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-23-015019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323015019/doc4.xml","form_type":"4"}},{"id":1862575,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T01:39:53.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 6, 2024 and (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-23-015019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323015019/doc4.xml","form_type":"4"}},{"id":1947235,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-17T20:11:17.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":78750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 15, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":78750,"derivative":{"exercise_price":1.34,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":78750},"source":{"system":"sec-edgar","filing":"0001567619-23-005255","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000156761923005255/doc1.xml","form_type":"4"}},{"id":2209240,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-11T20:14:25.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from July 7, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":52500,"derivative":{"exercise_price":1.41,"expiration_date":"2032-07-07","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001567619-22-013868","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000156761922013868/doc1.xml","form_type":"4"}},{"id":2220315,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T20:28:24.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year from June 8, 2022, subject to the Reporting Person's continuous service on the board of directors as of each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.9,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-22-024399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924322024399/doc4.xml","form_type":"4"}},{"id":2408521,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-08T21:08:33.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the Option will be fully vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":26250,"derivative":{"exercise_price":3.06,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001567619-22-002891","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000156761922002891/doc1.xml","form_type":"4"}},{"id":2408520,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-08T21:08:33.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":105000,"derivative":{"exercise_price":3.06,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001567619-22-002891","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000156761922002891/doc1.xml","form_type":"4"}},{"id":2958793,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-04T01:04:49.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":176237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's continued service to the Company through her one year anniversary as an employee with the issuer (which is May 31, 2021), 1/48th of the total number of shares subject to the option vest in forty-eight (48) successive and equal monthly installments measured from December 1, 2020 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":176237,"derivative":{"exercise_price":16.18,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":176237},"source":{"system":"sec-edgar","filing":"0001567619-20-020624","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000156761920020624/doc1.xml","form_type":"4"}},{"id":3131689,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-28T16:05:28.000Z","date":"2020-05-26","kind":"exercise","acquired":false,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option becomes exercisable in sixteen equal quarterly installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":900,"derivative":{"exercise_price":29.75,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0000899243-20-014410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320014410/doc4.xml","form_type":"4"}},{"id":3131688,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-28T16:05:28.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":2700,"price":70.1,"value":189270.0,"ownership":{"direct":true},"balance_after":154,"source":{"system":"sec-edgar","filing":"0000899243-20-014410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320014410/doc4.xml","form_type":"4"}},{"id":3131687,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-28T16:05:28.000Z","date":"2020-05-26","kind":"exercise","acquired":true,"shares":2700,"price":29.75,"value":80325.0,"ownership":{"direct":true},"balance_after":2854,"source":{"system":"sec-edgar","filing":"0000899243-20-014410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320014410/doc4.xml","form_type":"4"}},{"id":3140327,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-20T16:07:49.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":23330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option becomes exercisable with respect to 1/4th of the underlying shares on August 15, 2017 and with respect to an additional 1/12th of the underlying shares each quarter thereafter until fully vested on August 15, 2020, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":1875,"derivative":{"exercise_price":22,"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":23330},"source":{"system":"sec-edgar","filing":"0000899243-20-013683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320013683/doc4.xml","form_type":"4"}},{"id":3140326,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-20T16:07:49.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":23330,"price":74.67,"value":1742051.1,"ownership":{"direct":true},"balance_after":154,"source":{"system":"sec-edgar","filing":"0000899243-20-013683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320013683/doc4.xml","form_type":"4"}},{"id":3140325,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-20T16:07:49.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":23330,"price":22,"value":513260.0,"ownership":{"direct":true},"balance_after":23484,"source":{"system":"sec-edgar","filing":"0000899243-20-013683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320013683/doc4.xml","form_type":"4"}},{"id":3150231,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-13T18:08:03.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":2992,"price":78.3798,"value":234512.3616,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold ranging from $78.34 to $78.41 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":154,"source":{"system":"sec-edgar","filing":"0000899243-20-013018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320013018/doc4.xml","form_type":"4"}},{"id":3150230,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-05-13T18:08:03.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":381,"price":77.0492,"value":29355.7452,"ownership":{"direct":true},"balance_after":3146,"source":{"system":"sec-edgar","filing":"0000899243-20-013018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320013018/doc4.xml","form_type":"4"}},{"id":3226317,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-03-04T20:48:10.000Z","date":"2020-03-01","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":600,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0000899243-20-007087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007087/doc4.xml","form_type":"4"}},{"id":3226316,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-04T20:48:10.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":104,"price":63.96,"value":6651.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 300 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":3527,"source":{"system":"sec-edgar","filing":"0000899243-20-007087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007087/doc4.xml","form_type":"4"}},{"id":3226315,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-04T20:48:10.000Z","date":"2020-03-01","kind":"exercise","acquired":true,"shares":300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":3631,"source":{"system":"sec-edgar","filing":"0000899243-20-007087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320007087/doc4.xml","form_type":"4"}},{"id":3290508,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T20:52:20.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":14610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of Common Stock underlying the option vest in 16 equal quarterly installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The options are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":14610,"derivative":{"exercise_price":65.82,"expiration_date":"2030-02-02","underlying":"Common Stock","underlying_shares":14610},"source":{"system":"sec-edgar","filing":"0000899243-20-003048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/doc4.xml","form_type":"4"}},{"id":3290507,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-02-04T20:52:20.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":9160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":9160,"derivative":{"underlying":"Common Stock","underlying_shares":9160},"source":{"system":"sec-edgar","filing":"0000899243-20-003048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/doc4.xml","form_type":"4"}},{"id":3290506,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-02-04T20:52:20.000Z","date":"2020-02-01","kind":"exercise","acquired":false,"shares":2313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":13875,"derivative":{"underlying":"Common Stock","underlying_shares":2313},"source":{"system":"sec-edgar","filing":"0000899243-20-003048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/doc4.xml","form_type":"4"}},{"id":3290505,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-02-04T20:52:20.000Z","date":"2020-02-01","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0000899243-20-003048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/doc4.xml","form_type":"4"}},{"id":3290504,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-04T20:52:20.000Z","date":"2020-02-01","kind":"tax_withholding","acquired":false,"shares":1154,"price":65.26,"value":75310.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 3,063 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":3331,"source":{"system":"sec-edgar","filing":"0000899243-20-003048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/doc4.xml","form_type":"4"}},{"id":3290503,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-04T20:52:20.000Z","date":"2020-02-01","kind":"exercise","acquired":true,"shares":3063,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":4485,"source":{"system":"sec-edgar","filing":"0000899243-20-003048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/doc4.xml","form_type":"4"}},{"id":3290502,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-04T20:52:20.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":535,"price":36.68,"value":19623.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1422,"source":{"system":"sec-edgar","filing":"0000899243-20-003048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/doc4.xml","form_type":"4"}},{"id":3414722,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-09-13T16:45:24.000Z","date":"2019-09-11","kind":"sale","acquired":false,"shares":2765,"price":54.3567,"value":150296.2755,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold ranging from $54.32 to $54.36 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":887,"source":{"system":"sec-edgar","filing":"0000899243-19-023567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319023567/doc4.xml","form_type":"4"}},{"id":3422825,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-09-04T16:29:23.000Z","date":"2019-09-01","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":900,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0000899243-19-022728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319022728/doc4.xml","form_type":"4"}},{"id":3422824,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-09-04T16:29:23.000Z","date":"2019-09-01","kind":"tax_withholding","acquired":false,"shares":104,"price":45.98,"value":4781.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 300 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":3652,"source":{"system":"sec-edgar","filing":"0000899243-19-022728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319022728/doc4.xml","form_type":"4"}},{"id":3422823,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-09-04T16:29:23.000Z","date":"2019-09-01","kind":"exercise","acquired":true,"shares":300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":3756,"source":{"system":"sec-edgar","filing":"0000899243-19-022728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319022728/doc4.xml","form_type":"4"}},{"id":3446645,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-08-05T17:06:58.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":2312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":16188,"derivative":{"underlying":"Common Stock","underlying_shares":2312},"source":{"system":"sec-edgar","filing":"0000899243-19-021013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319021013/doc4.xml","form_type":"4"}},{"id":3446644,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-08-05T17:06:58.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0000899243-19-021013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319021013/doc4.xml","form_type":"4"}},{"id":3446643,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-08-05T17:06:58.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":1060,"price":54.25,"value":57505.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 3,062 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":3456,"source":{"system":"sec-edgar","filing":"0000899243-19-021013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319021013/doc4.xml","form_type":"4"}},{"id":3446642,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-08-05T17:06:58.000Z","date":"2019-08-01","kind":"exercise","acquired":true,"shares":3062,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":4516,"source":{"system":"sec-edgar","filing":"0000899243-19-021013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319021013/doc4.xml","form_type":"4"}},{"id":3446641,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-08-05T17:06:58.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":226,"price":36.68,"value":8289.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1454,"source":{"system":"sec-edgar","filing":"0000899243-19-021013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319021013/doc4.xml","form_type":"4"}},{"id":3610446,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-03-05T20:48:20.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":1200,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0000899243-19-006308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319006308/doc4.xml","form_type":"4"}},{"id":3610445,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-05T20:48:20.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":104,"price":53.48,"value":5561.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 300 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":1228,"source":{"system":"sec-edgar","filing":"0000899243-19-006308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319006308/doc4.xml","form_type":"4"}},{"id":3610444,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-05T20:48:20.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":1332,"source":{"system":"sec-edgar","filing":"0000899243-19-006308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319006308/doc4.xml","form_type":"4"}},{"id":3655888,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-14T17:29:12.000Z","date":"2019-02-12","kind":"sale","acquired":false,"shares":354,"price":50.453,"value":17860.362,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1032,"source":{"system":"sec-edgar","filing":"0000899243-19-003661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319003661/doc4.xml","form_type":"4"}},{"id":3655887,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-14T17:29:12.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":354,"price":36.68,"value":12984.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1386,"source":{"system":"sec-edgar","filing":"0000899243-19-003661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319003661/doc4.xml","form_type":"4"}},{"id":3655869,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-14T17:26:22.000Z","date":"2018-08-01","kind":"sale","acquired":false,"shares":258,"price":43.52,"value":11228.16,"ownership":{"direct":true},"balance_after":1032,"source":{"system":"sec-edgar","filing":"0000899243-19-003657","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319003657/doc5.xml","form_type":"5"}},{"id":3655868,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-14T17:26:22.000Z","date":"2018-07-03","kind":"sale","acquired":false,"shares":187,"price":44.88,"value":8392.56,"ownership":{"direct":true},"balance_after":1290,"source":{"system":"sec-edgar","filing":"0000899243-19-003657","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319003657/doc5.xml","form_type":"5"}},{"id":3655867,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-14T17:26:22.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":510,"price":54.68,"value":27886.8,"ownership":{"direct":true},"balance_after":1477,"source":{"system":"sec-edgar","filing":"0000899243-19-003657","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319003657/doc5.xml","form_type":"5"}},{"id":3655866,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-14T17:26:22.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":510,"price":21.34,"value":10883.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1987,"source":{"system":"sec-edgar","filing":"0000899243-19-003657","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319003657/doc5.xml","form_type":"5"}},{"id":3673506,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-02-05T17:53:20.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":4500,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0000899243-19-002667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319002667/doc4.xml","form_type":"4"}},{"id":3673505,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-02-05T17:53:20.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":18500,"derivative":{"underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0000899243-19-002667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319002667/doc4.xml","form_type":"4"}},{"id":3673504,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-05T17:53:20.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the option vest in 16 equal quarterly installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":13500,"derivative":{"exercise_price":48.44,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0000899243-19-002667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319002667/doc4.xml","form_type":"4"}},{"id":3673503,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-05T17:53:20.000Z","date":"2019-02-01","kind":"tax_withholding","acquired":false,"shares":307,"price":48.44,"value":14871.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 750 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":1477,"source":{"system":"sec-edgar","filing":"0000899243-19-002667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319002667/doc4.xml","form_type":"4"}},{"id":3673502,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-02-05T17:53:20.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":1784,"source":{"system":"sec-edgar","filing":"0000899243-19-002667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924319002667/doc4.xml","form_type":"4"}},{"id":3822962,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-09-06T20:05:14.000Z","date":"2018-09-01","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in eight equal semi-annual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0000899243-18-023971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318023971/doc4.xml","form_type":"4"}},{"id":3822961,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-06T20:05:14.000Z","date":"2018-09-04","kind":"tax_withholding","acquired":false,"shares":104,"price":48.95,"value":5090.8,"ownership":{"direct":true},"balance_after":1034,"source":{"system":"sec-edgar","filing":"0000899243-18-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318023971/doc4.xml","form_type":"4"}},{"id":3822960,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-06T20:05:14.000Z","date":"2018-09-01","kind":"exercise","acquired":true,"shares":300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":1138,"source":{"system":"sec-edgar","filing":"0000899243-18-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318023971/doc4.xml","form_type":"4"}},{"id":3837915,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-20T20:25:21.000Z","date":"2018-08-16","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option becomes exercisable with respect to 1/4th of the underlying shares on August 15, 2017 and with respect to an additional 1/12th of the underlying shares each quarter thereafter until fully vested on August 15, 2020, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Stock Option becomes exercisable with respect to 1/4th of the underlying shares on August 15, 2017 and with respect to an additional 1/12th of the underlying shares each quarter thereafter until fully vested on August 15, 2020, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":25205,"derivative":{"exercise_price":22,"underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000899243-18-022840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318022840/doc4.xml","form_type":"4"}},{"id":3837914,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-20T20:25:21.000Z","date":"2018-08-16","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option becomes exercisable with respect to 1/4th of the underlying shares on August 15, 2017 and with respect to an additional 1/12th of the underlying shares each quarter thereafter until fully vested on August 15, 2020, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Stock Option becomes exercisable with respect to 1/4th of the underlying shares on August 15, 2017 and with respect to an additional 1/12th of the underlying shares each quarter thereafter until fully vested on August 15, 2020, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":26205,"derivative":{"exercise_price":22,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000899243-18-022840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318022840/doc4.xml","form_type":"4"}},{"id":3837913,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-20T20:25:21.000Z","date":"2018-08-17","kind":"sale","acquired":false,"shares":300,"price":49.188,"value":14756.4,"ownership":{"direct":true},"balance_after":838,"source":{"system":"sec-edgar","filing":"0000899243-18-022840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318022840/doc4.xml","form_type":"4"}},{"id":3837912,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-20T20:25:21.000Z","date":"2018-08-16","kind":"sale","acquired":false,"shares":1500,"price":50.0135,"value":75020.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $50.0000 to $50.0304 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1138,"source":{"system":"sec-edgar","filing":"0000899243-18-022840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318022840/doc4.xml","form_type":"4"}},{"id":3837911,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-20T20:25:21.000Z","date":"2018-08-16","kind":"exercise","acquired":true,"shares":1000,"price":22,"value":22000.0,"ownership":{"direct":true},"balance_after":2638,"source":{"system":"sec-edgar","filing":"0000899243-18-022840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318022840/doc4.xml","form_type":"4"}},{"id":3837910,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-20T20:25:21.000Z","date":"2018-08-16","kind":"exercise","acquired":true,"shares":500,"price":22,"value":11000.0,"ownership":{"direct":true},"balance_after":1638,"source":{"system":"sec-edgar","filing":"0000899243-18-022840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318022840/doc4.xml","form_type":"4"}},{"id":3837909,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-20T20:25:21.000Z","date":"2018-08-16","kind":"sale","acquired":false,"shares":204,"price":49.969,"value":10193.676,"ownership":{"direct":true},"balance_after":1138,"source":{"system":"sec-edgar","filing":"0000899243-18-022840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318022840/doc4.xml","form_type":"4"}},{"id":3837908,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-20T20:25:21.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":204,"price":35.53,"value":7248.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":1342,"source":{"system":"sec-edgar","filing":"0000899243-18-022840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318022840/doc4.xml","form_type":"4"}},{"id":3852707,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-08-03T17:52:05.000Z","date":"2018-08-01","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in eight equal semi-annual installments after February 1, 2018 until fully vested on February 1, 2022, subject to the Reporting Person's continuous service with the Issuer.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in eight equal semi-annual installments after February 1, 2018 until fully vested on February 1, 2022, subject to the Reporting Person's continuous service with the Issuer.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason upon a change of control of the Issuer."}],"balance_after":5250,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0000899243-18-021424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318021424/doc4.xml","form_type":"4"}},{"id":3852706,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-03T17:52:05.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":1138,"source":{"system":"sec-edgar","filing":"0000899243-18-021424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318021424/doc4.xml","form_type":"4"}},{"id":3869881,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-10T18:10:16.000Z","date":"2018-07-09","kind":"exercise","acquired":false,"shares":2295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option becomes exercisable with respect to 1/4th of the underlying shares on August 15, 2017 and with respect to an additional 1/12th of the underlying shares each quarter thereafter until fully vested on August 15, 2020, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":26705,"derivative":{"exercise_price":22,"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":2295},"source":{"system":"sec-edgar","filing":"0000899243-18-019717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318019717/doc4.xml","form_type":"4"}},{"id":3869880,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-10T18:10:16.000Z","date":"2018-07-06","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option becomes exercisable with respect to 1/4th of the underlying shares on August 15, 2017 and with respect to an additional 1/12th of the underlying shares each quarter thereafter until fully vested on August 15, 2020, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":29000,"derivative":{"exercise_price":22,"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000899243-18-019717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318019717/doc4.xml","form_type":"4"}},{"id":3869879,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-07-10T18:10:16.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":2295,"price":44.274,"value":101608.83,"ownership":{"direct":true},"balance_after":388,"source":{"system":"sec-edgar","filing":"0000899243-18-019717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318019717/doc4.xml","form_type":"4"}},{"id":3869878,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-07-10T18:10:16.000Z","date":"2018-07-09","kind":"exercise","acquired":true,"shares":2295,"price":22,"value":50490.0,"ownership":{"direct":true},"balance_after":2683,"source":{"system":"sec-edgar","filing":"0000899243-18-019717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318019717/doc4.xml","form_type":"4"}},{"id":3869877,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-07-10T18:10:16.000Z","date":"2018-07-06","kind":"sale","acquired":false,"shares":1000,"price":44.005,"value":44005.0,"ownership":{"direct":true},"balance_after":388,"source":{"system":"sec-edgar","filing":"0000899243-18-019717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318019717/doc4.xml","form_type":"4"}},{"id":3869876,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-07-10T18:10:16.000Z","date":"2018-07-06","kind":"exercise","acquired":true,"shares":1000,"price":22,"value":22000.0,"ownership":{"direct":true},"balance_after":1388,"source":{"system":"sec-edgar","filing":"0000899243-18-019717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318019717/doc4.xml","form_type":"4"}},{"id":4013590,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-03-05T17:00:30.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":300,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The Restricted Stock Units are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."}],"balance_after":1800,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0000899243-18-006362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318006362/doc4.xml","form_type":"4"}},{"id":4013589,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-05T17:00:30.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":99,"price":60.35,"value":5974.65,"ownership":{"direct":true},"balance_after":388,"source":{"system":"sec-edgar","filing":"0000899243-18-006362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318006362/doc4.xml","form_type":"4"}},{"id":4013588,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-05T17:00:30.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."}],"balance_after":487,"source":{"system":"sec-edgar","filing":"0000899243-18-006362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318006362/doc4.xml","form_type":"4"}},{"id":4062024,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-02-13T21:28:53.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest in eight semi-annual installments after February 1, 2018 until fully vested on February 1, 2022, subject to the Reporting Person's continuous service with the Issuer.  The Restricted Stock Units are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-18-003750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003750/doc4.xml","form_type":"4"}},{"id":4062023,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-13T21:28:53.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option becomes exercisable in sixteen equal quarterly installments after February 1, 2018 until fully vested on February 1, 2022, subject to the Reporting Person's continuous service with the Issuer.  The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":9000,"derivative":{"exercise_price":59.6,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-18-003750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003750/doc4.xml","form_type":"4"}},{"id":4062021,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-02-13T21:27:08.000Z","date":"2017-09-01","kind":"exercise","acquired":false,"shares":300,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The Restricted Stock Units are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."}],"balance_after":2100,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0000899243-18-003749","document":"doc5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003749/doc5.xml","form_type":"5"}},{"id":4062020,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-02-13T21:27:08.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":2400,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in eight semiannual installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The Restricted Stock Units are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."}],"balance_after":2400,"derivative":{"underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0000899243-18-003749","document":"doc5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003749/doc5.xml","form_type":"5"}},{"id":4062019,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-13T21:27:08.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option becomes exercisable in sixteen equal quarterly installments after March 1, 2017 until fully vested on March 1, 2021, subject to the Reporting Person's continuous service with the Issuer. The Stock Option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":3600,"derivative":{"exercise_price":29.75,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":3600},"source":{"system":"sec-edgar","filing":"0000899243-18-003749","document":"doc5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003749/doc5.xml","form_type":"5"}},{"id":4062018,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-13T21:27:08.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":113,"price":30.3,"value":3423.9,"ownership":{"direct":true},"balance_after":187,"source":{"system":"sec-edgar","filing":"0000899243-18-003749","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003749/doc5.xml","form_type":"5"}},{"id":4062017,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-13T21:27:08.000Z","date":"2017-09-01","kind":"exercise","acquired":true,"shares":300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of GBT common stock."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0000899243-18-003749","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003749/doc5.xml","form_type":"5"}},{"id":4062016,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40536,"kind":"person","name":"Calhoun Lesley Ann","position":1,"cik":"0001730866","reported_name":"Calhoun Lesley Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-13T21:27:08.000Z","date":"2017-08-02","kind":"sale","acquired":false,"shares":1552,"price":27.23,"value":42260.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,552 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2017 in a transaction exempt under Rule 16b-3."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-003749","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003749/doc5.xml","form_type":"5"}}]}